RetiSpec
Toronto, Ontario, CanadaSee on the mapFounded 2016
- Series A
RetiSpec is a medical imaging company developing AI-powered technology to detect neurodegenerative diseases early. Its approach uses hyperspectral imaging of the eye to support disease detection.
- RaisedTotal raised
- $11.7M
- Jul 2024Latest priced round, Jul 2024
- Series A
- Investors
- 11
- Founded
- 2016
- Employees
- 11–50
reccy insights
RetiSpec's latest clearly dated financing milestone is its Series A, announced on Jul 26, 2024. The round raised approximately $9.98 million, with iGan Partners identified as lead investor; Eli Lilly and Company and Topcon Healthcare also appear among the associated investors. Earlier milestones include a $250,000 seed round dated Nov 1, 2019 and a $500,000 grant dated Oct 16, 2019. A further grant is listed on Apr 13, 2023, associated with the Centre for Aging + Brain Health Innovation. The company is developing a non-invasive retinal imaging approach intended to detect Alzheimer's-related pathology before symptoms appear, using AI and hyperspectral imaging. The disclosed information therefore points to continued development of its diagnostic technology and funding support, but does not establish clinical deployment, regulatory clearance, commercial sales, or a more recent financing event.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
What makes RetiSpec distinct
- 01Focuses on early detection of neurodegenerative diseases.
- 02Combines AI with hyperspectral imaging of the eye.
- 03Applies retinal imaging to the detection of neurodegenerative disease markers.
- 04Aims to support a non-invasive eye examination for early diagnosis.
Technology & products
- AI-powered medical imaging.
- Hyperspectral imaging of the eye for neurodegenerative disease detection.
Research roots1
Labs and research groups this company came from or works with.
- No page yetUniversity of MinnesotaMinneapolis, United StatesMinneapolis, United States · No page yetLicence
Recent updates3
- Jun 13, 2025Award
10 Innovators Making Healthcare More Accessible with AI
worth.com - Dec 13, 2024Partnership
RetiSpec Raises $10M & Partners to Bring Early Alzheimer's Detection Platform to More People
youtube.com - Dec 3, 2024Award
Digital Health 50: The most promising digital health startups of 2024
cbinsights.com
Funding
- Accelerator/IncubatorSep 2024
- Series AJul 2024$10MLed by iGan Partners, Eli Lilly and Company, Topcon Healthcare
- GrantApr 2023
Investors8
- Alzheimer's Drug Discovery
- iGan Partners
- Gentex Corporation
About RetiSpec
- Leadership
- Eliav ShakedRoy Kirshon
- Focus areas
- AI, healthcare, medical imaging, hyperspectral imaging, neurodegenerative diseases, ophthalmology, diagnostics, early detection
- Headquarters
- Toronto, Ontario, Canada
- Founded
- 2016
- Employees
- 11–50
- Status
- Active · private